The reason is NEU has too many shareholders who don’t understand their investment combined with a market that doesn’t understand biotech. It’s all good here.
On the ASX biotechs can make very positive announcements and they still get marked down heavily. There are many good opportunities including NEU up for grabs.
NEU Price at posting:
$1.19 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)